— Know what they know.
Not Investment Advice

XGN NASDAQ

Exagen Inc.
1W: -6.3% 1M: +8.8% 3M: +85.7% YTD: +35.3% 1Y: -25.6% 3Y: +222.9% 5Y: -40.1%
$8.17
+0.28 (+3.55%)
 
Weekly Expected Move ±6.8%
$7 $8 $8 $9 $9
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 58 · $197.4M mcap · 14M float · 2.36% daily turnover · Short 30% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$67M +19.7% ▲
5Y CAGR: +9.7%
Gross Profit
$39M +17.2% ▲
5Y CAGR: +8.8%
Operating Income
-$14M -3.2% ▼
Net Income
-$20M -32.0% ▼
EPS (Diluted)
$-0.93 -12.0% ▼
EBITDA
-$12M -7.2% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$48M$46M$53M$56M$67M
YoY Growth+15.1%-5.7%+15.3%+5.9%+19.7%
Cost of Revenue$21M$24M$23M$23M$28M
Gross Profit$28M$21M$29M$33M$39M
Gross Margin57.4%46.9%56.1%59.5%58.3%
R&D Expenses$7M$10M$5M$5M$6M
SG&A Expenses$45M$52M$47M$41M$47M
Operating Expenses$52M$67M$52M$47M$53M
Operating Income-$24M-$46M-$23M-$14M-$14M
Operating Margin-49.8%-101.1%-43.5%-24.5%-21.1%
Interest Expense$3M$2M$2M$2M$4M
Income Before Tax-$27M-$48M-$24M-$15M-$20M
Tax Expense$175K-$282K$33K$12K$51K
Net Income-$27M-$47M-$24M-$15M-$20M
Net Margin-55.6%-104.0%-45.1%-27.2%-30.0%
EPS (Diluted)$-1.68$-2.77$-1.34$-0.83$-0.93
EBITDA-$23M-$44M-$19M-$11M-$12M
Shares Outstanding16M17M18M18M22M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms